CompletedNCT02404194
This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 15 Years to 30 Years
- Countries
- United States
- Sponsor
- Rush University Medical Center
- Condition
- Schizophrenia
TerminatedNCT00591318
This study exists to see whether the medication IV can play a useful role in care. Researchers are trying to understand whether the medication IV can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Research Foundation for Mental Hygiene, Inc.
- Condition
- Schizophrenia
CompletedNCT03504579
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Harvard Medical School (HMS and HSDM)
- Condition
- Schizophrenia
CompletedNCT05042050
This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
SchizophreniaOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Schizophrenia
CompletedNCT03129360
This study exists to understand what helps blood tests and biological markers work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 16 Years to 35 Years
- Countries
- United States
- Sponsor
- NYU Langone Health
- Condition
- Schizophrenia
CompletedNCT02832401
This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Schizophrenia
CompletedNCT01592110
This study exists to better understand the safety of the medication Injectable and how manageable it feels in practice. Researchers are trying to understand whether the medication Injectable can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Zogenix, Inc.
- Condition
- Schizophrenia
CompletedNCT00845026
This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand how people respond to brain scans or other body measurements in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Germany, Mexico, Russian Federation, United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT02411526
This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Zogenix, Inc.
- Condition
- Schizophrenia
CompletedNCT05257720
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Turkey
- Sponsor
- Istanbul Saglik Bilimleri University
- Condition
- Schizophrenia
CompletedNCT04002258
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherOver 14 Years
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
- Condition
- Schizophrenia
CompletedNCT04094207
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Egypt
- Sponsor
- Sadat City University
- Condition
- Schizophrenia
CompletedNCT02294409
This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
AnxietyOtherFrom 18 Years to 35 Years
- Countries
- Canada
- Sponsor
- Douglas Mental Health University Institute
- Condition
- Anxiety
CompletedNCT01376596
This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
AnxietyOtherFrom 18 Years to 50 Years
- Countries
- Canada
- Sponsor
- Douglas Mental Health University Institute
- Condition
- Anxiety
TerminatedNCT01307800
This study exists to compare options and see whether the medication LY2140023 offers something meaningfully different. Researchers are trying to understand whether the medication LY2140023 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Mexico, United States, Russian Federation, Ukraine
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
WithdrawnNCT05338424
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
CompletedNCT05282329
This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- China
- Sponsor
- Tianjin Anding Hospital
- Condition
- Schizophrenia
CompletedNCT01555697
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT05556941
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 23 Years to 68 Years
- Countries
- Global
- Sponsor
- University of Haifa
- Condition
- Schizophrenia
CompletedNCT04176835
This study exists to see whether brain scans or other body measurements can make care clearer and more responsive. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- Global
- Sponsor
- National Institute of Mental Health and Neuro Sciences, India
- Condition
- Schizophrenia
CompletedNCT05115604
This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- Spain
- Sponsor
- David Batalla-Martin
- Condition
- Schizophrenia
CompletedNCT02006628
This study exists to compare options and see whether the medication GWP42003 offers something meaningfully different. Researchers are trying to understand whether the medication GWP42003 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Poland, Romania, United Kingdom
- Sponsor
- Jazz Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT04173572
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia
TerminatedNCT04103775
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 15 Years to 100 Years
- Countries
- United States
- Sponsor
- Colorado State University
- Condition
- Schizophrenia
TerminatedNCT04742413
This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Spain
- Sponsor
- Angelini Farmacéutica
- Condition
- Schizophrenia